Legacy Wealth Management (Mississippi)’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,045
Closed -$221K 100
2025
Q1
$221K Sell
3,045
-11,036
-78% -$790K 0.07% 93
2024
Q4
$1.04M Hold
14,081
0.41% 42
2024
Q3
$929K Buy
14,081
+4,605
+49% +$335K 0.34% 50
2024
Q2
$875K Hold
9,476
0.37% 46
2024
Q1
$906K Sell
9,476
-195
-2% -$16.4K 0.41% 45
2023
Q4
$737K Buy
9,671
+278
+3% +$19.3K 0.36% 50
2023
Q3
$651K Sell
9,393
-25
-0.3% -$2.01K 0.34% 54
2023
Q2
$888K Sell
9,418
-10
-0.1% -$869 0.45% 48
2023
Q1
$780K Hold
9,428
0.43% 48
2022
Q4
$703K Sell
9,428
-80
-0.8% -$6.17K 0.42% 48
2022
Q3
$786K Hold
9,508
0.53% 49
2022
Q2
$904K Sell
9,508
-104
-1% -$10.8K 0.55% 54
2022
Q1
$1.13M Buy
9,612
+47
+0.5% +$5.27K 0.59% 55
2021
Q4
$1.24M Buy
9,565
+33
+0.3% +$3.85K 0.63% 46
2021
Q3
$1.08M Hold
9,532
0.58% 51
2021
Q2
$987K Hold
9,532
0.55% 51
2021
Q1
$797K Hold
9,532
0.48% 54
2020
Q4
$870K Hold
9,532
0.55% 51
2020
Q3
$761K Hold
9,532
0.52% 52
2020
Q2
$659K Buy
9,532
+622
+7% +$44.2K 0.5% 58
2020
Q1
$560K Buy
+8,910
New +$643K 0.52% 57

Other funds holding EW

Legacy Wealth Management (Mississippi)'s EW Position: Q2 2025 in Review

Legacy Wealth Management (Mississippi) sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 3,045 shares — an estimated $221K sold.

Legacy Wealth Management (Mississippi) first reported a position in EW in Q1 2020 and held it in 21 quarters. The position peaked at $1.24M in Q4 2021. 1,259 funds tracked by Wall St. Rank hold EW as of Q2 2025.

  • Legacy Wealth Management (Mississippi) reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
  • Legacy Wealth Management (Mississippi) sold 3,045 Edwards Lifesciences shares in Q2 2025, an estimated $221K.
  • Legacy Wealth Management (Mississippi) first reported a position in Edwards Lifesciences in Q1 2020 and held it in 21 quarters.
  • Legacy Wealth Management (Mississippi)'s Edwards Lifesciences position peaked at $1.24M in Q4 2021.
  • 1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Legacy Wealth Management (Mississippi)'s 13F filing for Q2 2025, filed 1 Jul 2025.